Profile picture

Miss Jiayan Zhang

University of Manchester, Manchester (United Kingdom of Great Britain & Northern Ireland)
Follow
Logo ESC

Contributor content

EDEM2 is new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2
Presentation
EDEM2 is new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2
See more
EDEM2 is a new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2
Presentation
EDEM2 is a new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources